bromobenzene has been researched along with Alloxan Diabetes in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (66.67) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Apte, UM; Bucci, TJ; Manautou, JE; Mehendale, HM; Ronis, MJ; Shankar, K; Vaidya, VS | 1 |
Berman, ML; Harbison, RD; James, RC; Smith, AC | 1 |
Beck, LV; Sanders, RA; Watkins, JB | 1 |
3 other study(ies) available for bromobenzene and Alloxan Diabetes
Article | Year |
---|---|
Type 1 diabetic mice are protected from acetaminophen hepatotoxicity.
Topics: Acetaminophen; Alanine Transaminase; Analgesics, Non-Narcotic; Animals; Aspartate Aminotransferases; Bromobenzenes; Carbon Tetrachloride; Cell Division; Chemical and Drug Induced Liver Injury; Colchicine; Diabetes Mellitus, Experimental; Disease Models, Animal; DNA; Drug Therapy, Combination; Liver; Liver Regeneration; Male; Mice; Microsomes, Liver; Proliferating Cell Nuclear Antigen | 2003 |
Characterization of hyperthyroidism enhancement of halothane-induced hepatotoxicity.
Topics: Alanine Transaminase; Animals; Biotransformation; Bromobenzenes; Chemical and Drug Induced Liver Injury; Diabetes Mellitus, Experimental; Female; Halothane; Hyperthyroidism; Male; Mice; Necrosis; Rats; Sex Factors; Species Specificity; Starvation; Time Factors; Triiodothyronine | 1983 |
The effect of long-term streptozotocin-induced diabetes on the hepatotoxicity of bromobenzene and carbon tetrachloride and hepatic biotransformation in rats.
Topics: Animals; Biotransformation; Body Weight; Bromobenzenes; Carbon Tetrachloride; Cytochrome P-450 Enzyme System; Diabetes Mellitus, Experimental; Glutathione; Ketones; Liver; Male; Organ Size; Rats; Rats, Inbred Strains | 1988 |